Palantir, Short-seller
Digest more
Shares in Palantir fell as much as 9% in late trading on Tuesday amid a broad AI pullback and a critical short-seller report.
Palantir Technologies has created one of the most dramatic stories on Wall Street this year, defying conventional investment narratives. In 2025, it became the top-performing stock in the S&P 500, surging over 106% and at points climbing 144% from the start of the year—outpacing even AI heavyweights like Nvidia.
Short-seller Citron targets PLTR again, using a Databricks comparison to argue the stock is overvalued after its report sent shares falling.
3d
Barchart on MSNCitron Research Just Warned AGAIN on Palantir. How Should You Play PLTR Stock Here?
Citron Research says Palantir stock at $40 per share would still be an expensive AI stock to own. Wall Street recommends caution on PLTR shares as well.
The drop began after a broader market pullback but escalated fast; short seller Citron Research issued a scathing note that accused the company of being detached from fundamentals and analysis. Citron's Andrew Left compared Palantir's price-to-revenue multiple with OpenAI's recent $500 billion valuation;
Palantir shares tumbled Tuesday afternoon, extending recent losses as a high-profile short seller fueled worries the stock could be overvalued after a strong run earlier this year.
1d
Amazon S3 on MSNPalantir Continues To Decline In Pre-Market As Valuation Concerns Mount—Citron Research Targets Overvaluation
Palantir shares fell in premarket trading on Wednesday, extending losses after a steep drop on Tuesday, according to Benzinga. Citron Research issued a bearish report claiming Palantir is overvalued and disconnected from fundamentals.
2d
Stocktwits on MSNPalantir Retail Traders’ Sentiment Deflates Amid Short Attack: Key Levels To Watch As Stock Drops For Five Straight Sessions
Palantir stock was the top trending ticker on the Stocktwits platform late Tuesday, even as the stock dropped for a fifth straight session. The losing streak comes amid short seller Citron Research, run by Andrew Left,